These findings suggest that HMGCS2 may function as a tumor suppressor by inhibiting the glycolytic process, providing a prospective experimental basis for further investigation of HMGCS2 as a tumor suppressor in clear cell renal cell carcinoma. The gene discussed is HMGCS2; the disease is neoplasm.